Page last updated: 2024-11-04

sulfasalazine and HIV Coinfection

sulfasalazine has been researched along with HIV Coinfection in 8 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research Excerpts

ExcerptRelevanceReference
"Sulfasalazine, a drug commonly used to treat arthritis, has been shown to increase CD4 counts in people with HIV, substantially in some patients."3.69Sulfasalazine: arthritis drug increases CD4 count? ( Smith, D, 1995)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (75.00)18.2507
2000's0 (0.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feria-Garzón, MG1
Rugeles, MT2
Hernandez, JC1
Lujan, JA1
Taborda, NA2
Perdomo-Celis, F1
Feria, MG1
Disla, E2
Rhim, HR1
Reddy, A1
Taranta, A1
Njobvu, PD1
McGill, PE1
Adebajo, AO1
Smith, D1
Youssef, PP1
Bertouch, JV1
Jones, PD1

Other Studies

8 other studies available for sulfasalazine and HIV Coinfection

ArticleYear
Sulfasalazine as an Immunomodulator of the Inflammatory Process during HIV-1 Infection.
    International journal of molecular sciences, 2019, Sep-11, Volume: 20, Issue:18

    Topics: Adaptor Proteins, Signal Transducing; Adolescent; Adult; Apoptosis Regulatory Proteins; CD4-Positive

2019
A Low Frequency of IL-17-Producing CD8
    Frontiers in immunology, 2018, Volume: 9

    Topics: Adult; Anti-Inflammatory Agents; Antiretroviral Therapy, Highly Active; CD8-Positive T-Lymphocytes;

2018
Interleukin-2 as therapy for HIV disease.
    The New England journal of medicine, 1995, Jul-20, Volume: 333, Issue:3

    Topics: CD4 Lymphocyte Count; HIV Infections; Humans; Interleukin-2; Sulfasalazine

1995
Improvement in CD4 lymphocyte count in HIV-Reiter's syndrome after treatment with sulfasalazine.
    The Journal of rheumatology, 1994, Volume: 21, Issue:4

    Topics: Adult; Arthritis, Reactive; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; HIV Infections; Humans; Leuko

1994
Sulphasalazine in the treatment of HIV-related spondyloarthropathy.
    British journal of rheumatology, 1997, Volume: 36, Issue:3

    Topics: Adult; Female; HIV Infections; HIV-1; Humans; Joint Diseases; Male; Middle Aged; Spinal Diseases; Su

1997
Sulfasalazine and human immunodeficiency virus-associated reactive arthritis: comment on the article by Clegg et al.
    Arthritis and rheumatism, 1997, Volume: 40, Issue:10

    Topics: Anti-Inflammatory Agents; Arthritis, Reactive; Controlled Clinical Trials as Topic; HIV Infections;

1997
Sulfasalazine: arthritis drug increases CD4 count?
    AIDS treatment news, 1995, Mar-03, Issue:no 218

    Topics: Adjuvants, Immunologic; CD4 Lymphocyte Count; Cytokines; Free Radical Scavengers; HIV; HIV Infection

1995
Successful treatment of human immunodeficiency virus-associated Reiter's syndrome with sulfasalazine.
    Arthritis and rheumatism, 1992, Volume: 35, Issue:6

    Topics: Adult; Arthritis, Reactive; HIV; HIV Infections; Humans; Male; Sulfasalazine

1992